![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 13, 11480-11488, March 28, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The c-myb proto-oncogene plays a
central role in hematopoiesis and encodes a major translational product
of 75 kDa. c-Myb is highly expressed in immature hematopoietic cells,
and its expression is down-regulated during terminal differentiation.
Deregulated expression of c-Myb has been shown to block terminal
differentiation of hematopoietic cells. Here we have studied the
mechanism of action and the nature of target genes through which c-Myb
mediates the block in differentiation of 32Dcl3 murine myeloid cells.
We show that the ectopic overexpression of c-Myb in 32Dcl3 cells results in the overexpression of c-Myc. However, enforced expression of
c-Myc in 32Dcl3 cells did not alter the normal pattern of
differentiation. In addition, expression of dominant-negative mutants
of c-Myc relieved c-Myb-mediated block in differentiation. These
results led us to conclude that c-myc is a target gene of
c-Myb and activation of the c-myc gene is a necessary event
in Myb-mediated transformation. However, c-Myc expression alone is
inadequate to elicit the phenotypic effects seen with
Myb-mediated block in differentiation of myeloid cells, suggesting that
activation of additional transcriptional targets by c-Myb plays a
critical role in this process.
c-Myc Is Essential but Not Sufficient for c-Myb-mediated Block of
Granulocytic Differentiation*
§¶
,
, and
**
Fels Institute for Cancer Research and
Molecular Biology and the § M.D./Ph.D. Program, Temple
University School of Medicine, Philadelphia, Pennsylvania 19140 and the
¶ Department of Medicine, Montefiore Medical Center, Bronx, New
York 10467
*
This work was supported by Grant CA79086 from the NCI,
National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Both authors contributed equally to this work.
**
To whom correspondence should be addressed: Fels Institute for
Cancer Research and Molecular Biology, Temple University School of
Medicine, 3307 N. Broad St., Philadelphia, PA 19140. Tel.: 215-707-4307; Fax: 215-707-1454; E-mail: reddy@unix.temple.edu.
This article has been cited by other articles:
![]() |
K. O. Gudmundsson, L. Thorsteinsson, O. E. Sigurjonsson, J. R. Keller, K. Olafsson, T. Egeland, S. Gudmundsson, and T. Rafnar Gene Expression Analysis of Hematopoietic Progenitor Cells Identifies Dlg7 as a Potential Stem Cell Gene Stem Cells, June 1, 2007; 25(6): 1498 - 1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kumar, S. J. Baker, C. M. Lee, and E. P. Reddy Molecular Mechanisms Associated with the Regulation of Apoptosis by the Two Alternatively Spliced Products of c-Myb Mol. Cell. Biol., September 15, 2003; 23(18): 6631 - 6645. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |